OTTAVA Receives FDA Approval, Reshaping Surgical Robotics

Jul 26
2 min read

For years, one company defined robotic surgery. That changed this week.

From a landmark FDA authorization to advances in AI-powered surgical assistance, these are the five developments that mattered most in surgical innovation this week.

1. Johnson & Johnson Enters the U.S. Robotic Surgery Market

Johnson & Johnson's OTTAVA received FDA authorization for soft tissue surgery, marking the company's official entry into the U.S. robotic surgery market.

The table-integrated robotic system was cleared for procedures including gastric bypass, gastrectomy, cholecystectomy, small bowel resection, and hiatal hernia repair.

The approval represents the strongest competitive challenge to Intuitive Surgical in more than two decades.

As a new-generation robotic platform, OTTAVA signals that hospitals evaluating robotic surgery will soon have more meaningful choices than ever before.

Why it matters: Robotic surgery is no longer a one-company market.

2. Moon Surgical and KARL STORZ Join Forces

Moon Surgical announced a commercial partnership with KARL STORZ to accelerate adoption of its Maestro robotic assistant.

By combining robotic assistance with one of the world's leading surgical visualization companies, the collaboration strengthens the growing integration between robotics and advanced imaging technologies.

Rather than competing alone, companies are increasingly building ecosystems that combine hardware, software, and visualization into a single surgical platform.

Why it matters: Strategic partnerships are becoming just as important as new robotic systems.

3. First Single-Port Robotic Liver Transplant Reported

King Faisal Specialist Hospital reported the world's first liver transplant performed using a single-port robotic platform.

Liver transplantation is among the most technically demanding procedures in surgery.

Completing it through a single access point demonstrates how robotic technology continues to expand into increasingly complex operations once considered beyond the reach of minimally invasive surgery.

Why it matters: Robotic surgery is continuing to move beyond routine procedures into the most challenging operations in medicine.

4. Medtronic Expands AI in the Operating Room

Medtronic introduced Touch Surgery Aide, an AI-powered platform designed to provide intraoperative guidance and workflow support.

While robotic hardware often captures the headlines, intelligent software is rapidly becoming just as important.

AI systems that assist surgeons with workflow, decision support, and real-time guidance are emerging as a major driver of operating room innovation.

Why it matters: The future of surgical AI is not just robotics—it's intelligent software that supports surgeons during every procedure.

5. Competition Is Accelerating Across Surgical Robotics

OTTAVA's approval joins Medtronic's Hugo expansion, continued growth from CMR Surgical's Versius platform, and a wave of AI-enabled surgical technologies entering clinical practice.

After years of limited competition, the robotic surgery market is entering a new phase defined by multiple global players.

Why it matters: More competition drives faster innovation, greater hospital choice, and broader access to robotic surgery.

Trend to Watch

The next wave of competition will be driven less by robotic hardware alone and more by artificial intelligence, computer vision, workflow software, and connected surgical platforms.

The companies that successfully combine these technologies into a seamless surgical ecosystem will shape the next decade of innovation.